- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Natco Pharma Ltd. (NATP)
Natco Pharma Ltd. stock price live, this page displays NSE NATP stock exchange data. View the NATP premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Natco Pharma Ltd. real time stock price chart below.
What Is the Natco Pharma Ltd. Stock Price Today?
The Natco Pharma Ltd. stock price today is 1,034.75.
What Is the Stock Symbol for Natco Pharma Ltd.?
The stock symbol for Natco Pharma Ltd. is ""NATP.""
What Stock Exchange Does Natco Pharma Ltd. Trade On?
Natco Pharma Ltd. is listed and trades on the NSE stock exchange.
Is Natco Pharma Ltd. a Good Stock to Buy?
Determining whether Natco Pharma Ltd.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NATP quote. (ISIN: INE987B01026)
What Is the Natco Pharma Ltd. Stock Price Today?
The Natco Pharma Ltd. stock price today is 1,034.75.
What Is the Stock Symbol for Natco Pharma Ltd.?
The stock symbol for Natco Pharma Ltd. is ""NATP.""
What Stock Exchange Does Natco Pharma Ltd. Trade On?
Natco Pharma Ltd. is listed and trades on the NSE stock exchange.
Is Natco Pharma Ltd. a Good Stock to Buy?
Determining whether Natco Pharma Ltd.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NATP quote. (ISIN: INE987B01026)
1,034.75
+20.40(+2.01%)
Closed·
Fair Value
An estimate of a Natco Pharma Ltd.'s true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,011.05
1,043.00
52 wk Range
660.05
1,638.35
NATP Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 15 days
More Info
Fair Value
An estimate of a Natco Pharma Ltd.'s true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,011.051,043.00
52 wk Range
660.051,638.35
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.59%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.59%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
NATP Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Natco Pharma Ltd.'s true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
- Natco Pharma Ltd. receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Natco Pharma Ltd. receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Natco Pharma Ltd. receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Natco Pharma Ltd. receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Natco Pharma Ltd. receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Natco Pharma Ltd. receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Natco Pharma Ltd. receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Natco Pharma Ltd. Company Profile
NATCO Pharma Limited, a pharmaceutical company, engages in the developing, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally. It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; and APIs in various categories, such as oncology, central nervous system, pain management, and cardiovascular care. The company offers orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, it provides cardiology and diabetology products for the treatment of hypertension, stable angina, and CHF. Further, the company offers agro chemicals and biological pest management solutions for management of insects, diseases, and weeds across a range of crops. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.
Compare NATP to Peers and Sector
Metrics to compare | NATP | Peers Peers - average of corresponding metrics from companies closely matching NATP: ALKEM, JBCHEPHARM, LAURUSLABS, AJANTPHARM, TORNTPHARM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNATPPeersSector |
|---|---|---|---|---|
P/E Ratio | 9.7x | 34.8x | −0.5x | |
PEG Ratio | 0.27 | 0.97 | 0.00 | |
Price/Book | 2.4x | 5.7x | 2.6x | |
Price / LTM Sales | 4.1x | 6.5x | 3.2x | |
Upside (Analyst Target) | −8.0% | 2.8% | 42.7% | |
Fair Value Upside | Unlock | −6.3% | 5.8% | Unlock |
Earnings
Latest Release
May 28, 2025
EPS / Forecast
22.85 / 32.20
Revenue / Forecast
12.21B / 14.36B
People Also Watch
FAQ
What Stock Exchange Does Natco Pharma Ltd. Trade On?
Natco Pharma Ltd. is listed and trades on the Bombay Stock Exchange stock exchange.
What Is the Stock Symbol for Natco Pharma Ltd.?
The stock symbol for Natco Pharma Ltd. is "NATP."
What Is the Natco Pharma Ltd. Market Cap?
As of today, Natco Pharma Ltd. market cap is 185.21B.
What Is Natco Pharma Ltd.'s Earnings Per Share (TTM)?
The Natco Pharma Ltd. EPS (TTM) is 105.26.
When Is the Next Natco Pharma Ltd. Earnings Date?
Natco Pharma Ltd. will release its next earnings report on 06 Aug 2025.
From a Technical Analysis Perspective, Is NATP a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Natco Pharma Ltd. Stock Split?
Natco Pharma Ltd. has split 1 times.
How Many Employees Does Natco Pharma Ltd. Have?
Natco Pharma Ltd. has 4016 employees.
What is the current trading status of Natco Pharma Ltd. (NATP)?
As of 23 Jul 2025, Natco Pharma Ltd. (NATP) is trading at a price of 1,034.75, with a previous close of 1,014.35. The stock has fluctuated within a day range of 1,011.05 to 1,043.00, while its 52-week range spans from 660.05 to 1,638.35.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.